goragot wisedchaisri
University of Washington
Seattle, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Washington
Seattle, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Endocrine Hypertension Research Centre, Diamantina Institute, Faculty of Medicine, The University of Queensland
St Lucia, Australia
Review Editor
Pharmacology of Ion Channels and Channelopathies
School of Medicine, Hubei Minzu University
Enshi, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of California, Davis
Davis, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
The Ohio State University
Columbus, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Hong Kong University of Science and Technology
Kowloon, Hong Kong, SAR China
Review Editor
Pharmacology of Ion Channels and Channelopathies
Zhejiang University
Hangzhou, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of Michigan
Ann Arbor, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Xinxiang Medical University
Xinxiang, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
Fudan University
Shanghai, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
Zhejiang University
Hangzhou, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
East China Normal University
Shanghai, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
University of California, Davis
Davis, United States
Review Editor
Pharmacology of Ion Channels and Channelopathies
Zhejiang University
Hangzhou, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
The Chinese University of Hong Kong
Shatin, China
Review Editor
Pharmacology of Ion Channels and Channelopathies
School of Biological Science and Medical Engineering, Beihang University
Beijing, China
Review Editor
Pharmacology of Ion Channels and Channelopathies